Ocular Therapeutix (OCUL) Other Operating Expenses (2013 - 2026)

Over the trailing twelve months to Jun 30, 2026, Ocular Therapeutix reported Other Operating Expenses of $66.61 million, up 20.5% year-over-year; for FY2025, it came in at $60.5 million, up 28.1% from FY2024.

• Other Operating Expenses has increased in each of the last seven years, with a five-year compound annual growth rate of 16.1% (FY2020 to FY2025).
• Going back by year, Other Operating Expenses was $47.22 million in FY2024 (+3.0%), $45.83 million in FY2023 (+3.1%), $44.46 million in FY2022 (+12.3%) and $39.6 million in FY2021 (+38.0%).
• The Q2 2026 figure represents the highest quarterly Other Operating Expenses in data going back to Q2 2013.
• Year-over-year, Other Operating Expenses has increased for eight consecutive quarters, with growth averaging 22.4% over the last eight quarters.
• The fastest year-over-year change in Other Operating Expenses over five years came in Q3 2021 (growth of 56.2%), and the weakest in Q4 2023 (a decline of 7.9%).
• Business Quant data shows OCUL's Other Operating Expenses at $17.91 million (Q1 2026), $14.55 million (Q4 2025) and $14.86 million (Q3 2025) in the three quarters before Q2 2026.